BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27882404)

  • 1. Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
    Yamamura S; Izumiya Y; Ishida T; Onoue Y; Kimura Y; Hanatani S; Araki S; Fujisue K; Sueta D; Kanazawa H; Takashio S; Usuku H; Sugamura K; Sakamoto K; Yamamoto E; Yamamuro M; Yasuda H; Kojima S; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
    Heart Vessels; 2017 Jun; 32(6):708-713. PubMed ID: 27882404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and
    Ochi Y; Kubo T; Nakashima Y; Baba Y; Hirota T; Yamasaki N; Yamashita T; Ueda M; Ando Y; Kitaoka H
    J Cardiol; 2020 Jan; 75(1):12-19. PubMed ID: 31324572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
    Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
    Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
    Gagliardi C; Perfetto F; Lorenzini M; Ferlini A; Salvi F; Milandri A; Quarta CC; Taborchi G; Bartolini S; Frusconi S; Martone R; Cinelli MM; Foffi S; Reggiani MLB; Fabbri G; Cataldo P; Cappelli F; Rapezzi C
    Eur J Heart Fail; 2018 Oct; 20(10):1417-1425. PubMed ID: 30070416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
    López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
    Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
    [No Abstract]   [Full Text] [Related]  

  • 8. The mitral L wave: a marker of pseudonormal filling and predictor of heart failure in patients with left ventricular hypertrophy.
    Lam CS; Han L; Ha JW; Oh JK; Ling LH
    J Am Soc Echocardiogr; 2005 Apr; 18(4):336-41. PubMed ID: 15846161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.
    Yunis A; Doros G; Luptak I; Connors LH; Sam F
    Am J Cardiol; 2019 Jul; 124(1):122-130. PubMed ID: 31053293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
    Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.
    González-López E; Gagliardi C; Dominguez F; Quarta CC; de Haro-Del Moral FJ; Milandri A; Salas C; Cinelli M; Cobo-Marcos M; Lorenzini M; Lara-Pezzi E; Foffi S; Alonso-Pulpon L; Rapezzi C; Garcia-Pavia P
    Eur Heart J; 2017 Jun; 38(24):1895-1904. PubMed ID: 28329248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis.
    Rubin J; Steidley DE; Carlsson M; Ong ML; Maurer MS
    J Card Fail; 2018 Aug; 24(8):504-511. PubMed ID: 30010028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.
    Mints YY; Doros G; Berk JL; Connors LH; Ruberg FL
    ESC Heart Fail; 2018 Oct; 5(5):772-779. PubMed ID: 29916559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triphasic mitral inflow velocity with mid-diastolic flow: the presence of mid-diastolic mitral annular velocity indicates advanced diastolic dysfunction.
    Ha JW; Ahn JA; Moon JY; Suh HS; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
    Eur J Echocardiogr; 2006 Jan; 7(1):16-21. PubMed ID: 16378917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tafamidis on the left ventricular and left atrial strain in patients with wild-type transthyretin cardiac amyloidosis.
    Nishizawa RH; Kawano H; Yoshimuta T; Eguchi C; Kojima S; Minami T; Sato D; Eguchi M; Okano S; Ikeda S; Ueda M; Maemura K
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):678-686. PubMed ID: 38109497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular diastolic dysfunction in essential hypertension.
    Avdić S; Mujcinović Z; Asćerić M; Nukić S; Kusljugić Z; Smajić E; Arapcić S
    Bosn J Basic Med Sci; 2007 Feb; 7(1):15-20. PubMed ID: 17489762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis.
    Rosenbaum AN; AbouEzzeddine OF; Grogan M; Dispenzieri A; Kushwaha S; Clavell A; Daly RC; Edwards BS
    Transplantation; 2018 Nov; 102(11):1909-1913. PubMed ID: 29677073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A pulsed Doppler study of left atrial and ventricular inflow in 2 populations of normotensive and hypertensive subjects].
    Arroja I; Azevedo J; Jacques A; Oliveira A; Amado P; do Valle JC; Marques JC; Araújo V
    Rev Port Cardiol; 1993 Oct; 12(10):827-39, 804. PubMed ID: 8286131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.